CLINICAL ROLE -
Lebrikizumab Demonstrates Improvements in Skin Clearance, Itch Relief in Patients With Atopic Dermatitis
At weeks 16 and 24, approximately 57% and 60% of patients with moderate to severe atopic dermatitis, respectively, achieved at least 75% improvement in Eczema Area and Severity Index score.